# Composite Flour and Its Antdiabetic Potential

> **NCT05163587** · NA · COMPLETED · sponsor: **University of Veterinary and Animal Sciences, Lahore - Pakistan** · enrollment: 46 (actual)

## Conditions studied

- Blood Glucose, High
- Body Weight Changes
- Hyperlipidemias
- Body Composition

## Interventions

- **COMBINATION_PRODUCT:** low GI composite flour

## Key facts

- **NCT ID:** NCT05163587
- **Lead sponsor:** University of Veterinary and Animal Sciences, Lahore - Pakistan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-26
- **Primary completion:** 2021-12-05
- **Final completion:** 2021-12-30
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2024-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05163587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05163587, "Composite Flour and Its Antdiabetic Potential". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05163587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*